CD44 and brain injury: Current data demonstrated that JNK‐IN‐8 exerted a neuroprotective and anti‐inflammatory effect and suppressed JNK activation and nuclear factor‐κB (NF‐κB) signaling activation in ischemic brain injury, proposing a potent treatment for ischemic brain injury.